5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.50▲ | 5.53▼ | 5.52▼ | 5.59▼ | 5.45▲ |
MA10 | 5.51▲ | 5.52▼ | 5.56▼ | 5.48▲ | 6.21▼ |
MA20 | 5.53▼ | 5.55▼ | 5.57▼ | 5.51▲ | 6.09▼ |
MA50 | 5.54▼ | 5.56▼ | 5.50▲ | 6.34▼ | 5.34▲ |
MA100 | 5.58▼ | 5.50▲ | 5.50▲ | 6.25▼ | 5.07▲ |
MA200 | 5.54▼ | 5.50▲ | 5.98▼ | 5.82▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.006▼ | -0.015▼ | 0.054▲ | N/A |
RSI | 47.446▼ | 46.195▼ | 47.633▼ | 43.370▼ | N/A |
STOCH | 31.548 | 42.708 | 27.822 | 65.351 | 21.822 |
WILL %R | -57.895 | -79.167▼ | -74.359 | -48.039 | -74.194 |
CCI | -19.391 | -64.413 | -79.876 | 35.636 | -52.111 |
Thursday, January 21, 2021 11:01 PM
Equities research analysts expect Aquestive Therapeutics, Inc. (NASDAQ:AQST) to report $6.43 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued ...
|
Saturday, January 16, 2021 03:52 AM
Zacks Investment Research lowered shares of Aquestive Therapeutics (NASDAQ:AQST) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning, Zacks.com reports.
|
Monday, January 04, 2021 05:30 AM
WARREN, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/01/21 | 5.71 | 5.72 | 5.43 | 5.53 | 649,793 |
25/01/21 | 5.72 | 5.81 | 5.40 | 5.65 | 869,777 |
22/01/21 | 5.64 | 5.7189 | 5.4857 | 5.67 | 595,036 |
21/01/21 | 5.55 | 5.7902 | 5.34 | 5.62 | 891,602 |
20/01/21 | 5.52 | 5.547 | 5.235 | 5.48 | 882,457 |
19/01/21 | 5.45 | 5.53 | 5.32 | 5.44 | 684,150 |
15/01/21 | 5.55 | 5.59 | 5.24 | 5.33 | 626,149 |
14/01/21 | 5.32 | 5.75 | 5.27 | 5.52 | 1,462,078 |
13/01/21 | 5.34 | 5.47 | 5.12 | 5.29 | 529,600 |
12/01/21 | 5.46 | 5.46 | 5.18 | 5.27 | 564,188 |
|
|
||||
|
|
||||
|
|